Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to ...

PARIS: Renault SA's impending loss of chief executive officer Luca de Meo calls into question the French carmaker's brittle restoration, with the board having to replace a second senior leader in a ...

Medtronic's stock has been an underwhelming investment to hold on to in recent years. While it's up around 4% this year, over a five-year period its returns are negative -- down 15%.

From product launches to acquisitions, here are seven updates from Medtronic so far in 2025. 1. Medtronic acquired rights and intellectual property related to Nanovis’ Sites Medical’s OsteoSync ...

Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT (10:00 a.m. CDT). Immediately following the presentation, Martha will be ...

Medtronic plc (NYSE:MDT) Q4 2025 Earnings Call Transcript May 21, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.62, expectations were $1.58. Operator: Good morning. I’m Ryan ...

Medtronic reported a fourth quarter global revenue of nearly $9 billion on Wednesday, totaling more than $33.5 billion globally for fiscal year 2025.

Medical-device maker Medtronic MDT -0.13% plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently ...

CFO Thierry Pieton told Reuters Medtronic plans to implement cost-saving measures to offset tariff impacts, and will seek exemptions due to the humanitarian nature of products.

Q4 revenue of $8.9 billion increased 3.9% as reported and 5.4% organic Q4 GAAP diluted EPS of $0.82 increased 67%; non-GAAP diluted EPS of $1.62 increased 11% Q4 operating margin increased 380 ...